300 related articles for article (PubMed ID: 18931699)
1. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62.
Pursiheimo JP; Rantanen K; Heikkinen PT; Johansen T; Jaakkola PM
Oncogene; 2009 Jan; 28(3):334-44. PubMed ID: 18931699
[TBL] [Abstract][Full Text] [Related]
2. p62/SQSTM1 regulates cellular oxygen sensing by attenuating PHD3 activity through aggregate sequestration and enhanced degradation.
Rantanen K; Pursiheimo JP; Högel H; Miikkulainen P; Sundström J; Jaakkola PM
J Cell Sci; 2013 Mar; 126(Pt 5):1144-54. PubMed ID: 23345396
[TBL] [Abstract][Full Text] [Related]
3. p62 degradation by autophagy: another way for cancer cells to survive under hypoxia.
Jaakkola PM; Pursiheimo JP
Autophagy; 2009 Apr; 5(3):410-2. PubMed ID: 19197142
[TBL] [Abstract][Full Text] [Related]
4. Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells.
Kwon SJ; Song JJ; Lee YJ
Clin Cancer Res; 2005 Nov; 11(21):7607-13. PubMed ID: 16278378
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells.
Sasabe E; Yang Z; Ohno S; Yamamoto T
Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165
[TBL] [Abstract][Full Text] [Related]
6. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
7. Autophagic degradation of the androgen receptor mediated by increased phosphorylation of p62 suppresses apoptosis in hypoxia.
Mitani T; Minami M; Harada N; Ashida H; Yamaji R
Cell Signal; 2015 Oct; 27(10):1994-2001. PubMed ID: 26186973
[TBL] [Abstract][Full Text] [Related]
8. Regulation of gene expression by the hypoxia-inducible factors.
Fedele AO; Whitelaw ML; Peet DJ
Mol Interv; 2002 Jul; 2(4):229-43. PubMed ID: 14993394
[TBL] [Abstract][Full Text] [Related]
9. Activation of hypoxia-induced transcription in normoxia.
Hägg M; Wennström S
Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
[TBL] [Abstract][Full Text] [Related]
10. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
Koshikawa N; Takenaga K
Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasion.
Heikkinen PT; Nummela M; Jokilehto T; Grenman R; Kähäri VM; Jaakkola PM
Cancer Res; 2010 Jul; 70(14):5984-93. PubMed ID: 20551054
[TBL] [Abstract][Full Text] [Related]
13. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery.
Alcaide-German ML; Vara-Vega A; Garcia-Fernandez LF; Landazuri MO; del Peso L
BMC Cell Biol; 2008 Apr; 9():18. PubMed ID: 18402654
[TBL] [Abstract][Full Text] [Related]
14. Prolyl 4-hydroxylases, master regulators of the hypoxia response.
Myllyharju J
Acta Physiol (Oxf); 2013 Jun; 208(2):148-65. PubMed ID: 23489300
[TBL] [Abstract][Full Text] [Related]
15. Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels.
Kim JH; Hong SK; Wu PK; Richards AL; Jackson WT; Park JI
Exp Cell Res; 2014 Oct; 327(2):340-52. PubMed ID: 25128814
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the hypoxia-sensing pathway in Drosophila melanogaster.
Arquier N; Vigne P; Duplan E; Hsu T; Therond PP; Frelin C; D'Angelo G
Biochem J; 2006 Jan; 393(Pt 2):471-80. PubMed ID: 16176182
[TBL] [Abstract][Full Text] [Related]
17. HIF prolyl 4-hydroxylases and their potential as drug targets.
Myllyharju J
Curr Pharm Des; 2009; 15(33):3878-85. PubMed ID: 19671043
[TBL] [Abstract][Full Text] [Related]
18. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
19. Expression of the cellular oxygen sensor PHD2 (EGLN-1) predicts radiation sensitivity in squamous cell cancer of the head and neck.
Luukkaa M; Jokilehto T; Kronqvist P; Vahlberg T; Grénman R; Jaakkola P; Minn H
Int J Radiat Biol; 2009; 85(10):900-8. PubMed ID: 19639506
[TBL] [Abstract][Full Text] [Related]
20. Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma.
Liu XW; Cai TY; Zhu H; Cao J; Su Y; Hu YZ; He QJ; Yang B
Autophagy; 2014 Jan; 10(1):111-22. PubMed ID: 24220190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
